Subclassification of tumors based on molecular features may facilitate therapeutic choice and increase the response rate of cancer patients. However, the highly complex cell origin involved in ...
Myeloid malignancies have so far been classified according to the revised 4th edition of World Health Organization Classification of Haematolymphoid Tumours, published in 2017 (WHO 2017, [1]) - the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results